Providing drug benefits under Medicare, America’s health-care program for the aged, may have been the right decision. But restricting government’s ability to bargain with the drug companies was a pure give-away, and nothing justifies providing grossly distorted information about the costs—now estimated to be in excess of 1.1 trillion over the next decade.